"

欢迎光临⚽彩票平台注册✅lbwlbw.com 亚洲信誉综合游戏公司✅彩票平台注册_多款游戏集于一体_顶尖原生app_彩票平台注册|非常注重玩家体验⚽邀请您入住

      <output id="hlxft"><span id="hlxft"></span></output>
      <form id="hlxft"><th id="hlxft"><progress id="hlxft"></progress></th></form>

        <address id="hlxft"></address>

          <noframes id="hlxft">

            <noframes id="hlxft"><address id="hlxft"><listing id="hlxft"></listing></address>
            <address id="hlxft"></address>
            <noframes id="hlxft"><address id="hlxft"><listing id="hlxft"><meter id="hlxft"></meter></listing></address>
              <listing id="hlxft"></listing>
              <span id="hlxft"></span>
              <address id="hlxft"></address>

              <form id="hlxft"><nobr id="hlxft"><progress id="hlxft"></progress></nobr></form>

              <noframes id="hlxft"><form id="hlxft"><nobr id="hlxft"></nobr></form><address id="hlxft"></address>
              "

              I. Development of therapeutic antibody against specific targets by combinatorial antibody libraries:
              Human combinatorial antibody libraries contain 1011 diversity. We apply this antibody libraries to therapeutic targets in major diseases such as cancer, diabetes and neuronal diseases. New functional antibodies may provide novel therapeutic strategies for diseases.



              II. Unbiased functional antibody screening by combinatorial antibody libraries:

              We have established an efficient method for identification of novel therapeutic targets by using combinatorial antibody libraries. In this method, we screen functional antibodies against specific disease models and identify the targets by proteomic analysis. By this approaches, we are aiming to discover novel therapeutic targets and propose new functional antibodies.

              彩票平台注册